Role of Infectious Diseases Consultants in Management of Antimicrobial Use in Hospitals

Sunenshine, Rebecca H.; Liedtke, Laura A.; Jernigan, Daniel B.; Strausbaugh, Larry J.
April 2004
Clinical Infectious Diseases;4/1/2004, Vol. 38 Issue 7, p934
Academic Journal
The Infectious Diseases Society of America Emerging Infections Network (EIN) surveyed its members to characterize antimicrobial restriction policies in their hospitals and the involvement of infectious diseases consultants in this process. Of the 502 respondents (73%), 250 (50%) indicated that their hospital pharmacies would not dispense certain antimicrobials without approval of infectious diseases consultants. Moreover, 89% agreed that infectious diseases consultants need to be directly involved in the approval process. At hospitals with control policies, commonly restricted agents included lipid formulations of amphotericin B, carbapenems, fluoroquinolones, piperacillin-tazobactam, and vancomycin. Only 46 EIN members (18%) reported remuneration of infectious diseases consultants for participation in the approval process. Pediatric infectious diseases consultants were more likely to practice in hospitals with restriction policies than were adult infectious diseases consultants (64% vs. 45%; ). Similarly, teaching hospitals were more likely to have antimicrobial- P< .001 control policies than were nonteaching facilities (60% vs. 17%; ). P<.001.


Related Articles

  • Vancomycin versus Placebo for Treating Persistent Fever in Patients with Neutropenic Cancer Receiving Piperacillin-Tazobactam Monotherapy. Cometta, A.; Kern, W.V.; De Bock, R.; Paesmans, M.; Vandenbergh, M.; Crokaert, F.; Engelhard, D.; Marchetti, O.; Akan, H.; Skoutelis, A.; Korten, V.; Vandercam, M.; Gaya, H.; Padmos, A.; Klastersky, J.; Zinner, S.; Glauser, M.P.; Calandra, T.; Viscoli, C. // Clinical Infectious Diseases;8/1/2003, Vol. 37 Issue 3, p382 

    Assesses whether the addition of a glycopeptide would be able to reduce the time to defervescence in neutropenic patients with cancer. Patients' persistent fever after the initiation of empirical piperacillin-tazobactam monotherapy' Addition of amphotericin B to the therapy regimen; Lack of...

  • Polymicrobial chronic endophthalmitis diagnosed by culture and molecular technique. Mukherjee, A.; Pramanik, S.; Das, D.; Roy, R.; Therese, K. L. // Indian Journal of Medical Microbiology;Jul-Sep2014, Vol. 32 Issue 3, p331 

    Accurate etiological diagnosis is the key to prevention of ocular morbidity in endophthalmitis cases. A 66 year old male was suffering from chronic endophthalmitis post-cataract surgery. Polymerase chain reaction examination on anterior chamber fluid was positive for Propionibacterium acnes but...

  • Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infection. DeRyke, C. Andrew; Kuti, Joseph L.; Mansfield, Debra; Dana, Adrian; Nicolau, David P. // American Journal of Health-System Pharmacy;4/15/2006, Vol. 63 Issue 8, p750 

    The article analyzes clinical trial data to determine whether the costs associated with the administration of piperacillin-tazobactum can be minimized by continuous-infusion regimens. There was no difference between the continuous infusion of piperacillin-tazobactum 13.5 gram daily and...

  • Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. Ralf Rene Reinert; Donald E. Low; Flávia Rossi; Xiaojiang Zhang; Chand Wattal; Michael J. Dowzicky // Journal of Antimicrobial Chemotherapy (JAC);Nov2007, Vol. 60 Issue 5, p1018 

    Objectives To describe antimicrobial susceptibility among bacterial isolates associated with hospital infections collected from 266 centres in Asia/Pacific Rim (n = 1947), North America (n = 24 283), Latin America (n = 1957) and Europe (n = 8796). Methods Isolates were collected from blood,...

  • Untitled.  // Biomedical Market Newsletter;12/20/2010, p35 

    The article reports on the worldwide voluntary product correction of VITEK(R) 2 Gram Negative Susceptibility Cards containing the antibiotic Piperacillin/Tazobactam (TZPv) undertaken by bioMérieux, Inc. It is reported that, the company initiated the correction on September 16, 2010, after the...

  • Distribution of Locally Delivered Antimicrobials Is Limited by Cortical Bone: A Pilot Study. Odgers, Ryan; Jarbo, Keith; McLaren, Alex; McLemore, Ryan // Clinical Orthopaedics & Related Research;Oct2013, Vol. 471 Issue 10, p3141 

    Background: Local delivery is required to achieve the high antimicrobial concentrations needed to treat biofilm-forming infections. The delivery site is commonly either in the intramedullary canal or at the periosteal surface. It is unknown whether locally delivered antimicrobials are...

  • Successful Treatment of Amphotericin Resistant Neuro-Aspergillosis in an Immunocompetent Patient with Oral Voriconazole. Khan, Ejaz A.; Raja, Nazarullah; Iqbal, Zafar; Chaudhry, Yousaf; Khan, Inayatullah // Infectious Disease Journal of Pakistan;Jan2012, Vol. 21 Issue 1, p408 

    Neuroaspergillosis in immunocompetent adults can present as a diagnostic and therapeutic challenge. We report an unusual case a 57-year-old male who presented with chronic persistent headaches, vertigo, memory loss, low-grade fever and left facial pain for more than a year. He had received...

  • Cryptococcus neoformans Prosthetic Joint Infection: Case Report and Review of the Literature. Shah, Neel; Shoham, Shmuel; Nayak, Seema // Mycopathologia;Apr2015, Vol. 179 Issue 3/4, p275 

    A 77-year-old woman with diabetes mellitus, myasthenia gravis and bilateral total hip arthroplasties underwent a two-stage procedure followed by treatment with vancomycin for a coagulase-negative staphylococcal prosthetic hip infection. This was complicated by a spontaneous left hip dislocation...

  • Putting a 'LID' on Antibiotic Use in Long-term Care Settings. John, Joseph F. // Infectious Disease Alert;Dec2012, Vol. 32 Issue 3, p35 

    Introduction of a long-term care facility (LTcF) infectious disease (ID) consultation service (LID) led to a significant reduction in total antimicrobial use. Bringing providers with ID expertise to LTcF represents a new and effective means to achieve antimicrobial stewardship.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics